FDA Approves Apalutamide (Erleada); the first treatment for non-metastatic castration-resistant prostate cancer (READ MORE HERE).
Exosomal RNAs as Serum Prostate Cancer Biomarkers—Personalized..
Fred Hutchinson Cancer Research Center and University of Washington
One of the challenges in prostate cancer..
Barry Taylor, PhD:
University of California, San Fransisco
Charles Sawyers, MD and Chris Sander, PhD
Dr. Tomlins earned a BA in Biology,..
Scott Tomlins, PhD:
University of Michigan – Ann Arbor, MI
Dr. Tagawa earned a BS in Biology..
Scott Tagawa, MD:
Weill Cornell Medical College – New York, NY
Targeting TMPRSS2-ERG in Prostate Cancer Approximately half..
David Y. Takeda, MD, PhD:
Dana Farber Cancer Institute
Todd Golub, MD, Levi Garraway, MD, PhD, William Hahn, MD, PhD
Treatment of advanced, metastatic prostate cancer, although..
Daniel Thorek, PhD:
Johns Hopkins University
David Scheinberg, MD, PhD and Steve Larson, MD
Alpha-particle therapy by 225Actinium-labeled prostate kallikrein-specific antibody to eradicate advanced disease
Nestled in the Pacific Northwest, the Seattle..